JIMSMENews

Follow us : Mail

Standalone PAT of Rs.3.09 crore at Beta Drugs in HY2 FY19-20


Beta Drugs announced its standalone and consolidated financial results for the half year ended on March 31, 2020.

Company : Beta Drugs Limited

Standalone total revenue at Beta Drugs was Rs.31.38 crore followed by net profit of Rs.3.09 crore and earning per share stood at Rs.3.26 in HY2 for FY2019-20.

Standalone revenue for the year was Rs.65.73 crore and net profit reached Rs.7.09 crore.

The companys consolidated total revenue at Beta Drugs was Rs.44.40 crore, net profit was Rs.4.29 crore and earning per share stood at Rs.4.53 in HY2 for FY2019-20.

Consolidated revenue for the tear was Rs.91.21crore and profit after tax reached Rs.9.41 crore

Result
Rs. in Crores
Current Year Upto Previous Year Upto Previous Year
31/3/2020 31/3/2019 2019-2020
Income Statement
Revenue 31.09 28.70 65.31
Other Income 0.29 0.01 0.42
Total Income 31.38 28.71 65.73
Expenditure 26.03 23.96 53.57
Finance Cost 0.40 0.28 0.64
PBDT 4.95 4.47 11.52
Depreciation 1.52 1.23 2.57
PBT 3.43 3.24 8.95
Tax 0.34 -1.05 1.86
Net Profit 3.09 4.29 7.09
Equity 9.61 8.64 9.61
EPS 3.26 4.96 7.49

Recent Stories

Weekly Journal

Get weekly updates on latest SME news in your e-mail.


Weekly Journal
Get weekly updates on latest SME news in your e-mail.
Terms of Use |Privacy Policy
Copyright © 2019 JimSMEnews. The JimSMEnews is not responsible for the content of external sites. Read about our approach to external linking.